Schonfeld Strategic Advisors LLC Mersana Therapeutics, Inc. Put Options Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MRSN
# of Institutions
115Shares Held
98MCall Options Held
16.3KPut Options Held
13K-
Nextech Invest, Ltd. Zurich, V812.1MShares$3.98 Million0.97% of portfolio
-
Nextech Invest Ag12.1MShares$3.98 Million3.22% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$2.86 Million0.99% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$2.77 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$2.76 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $32.1M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...